Brain: Tumours
Commons · Question 21813 · Tabled 28 Aug 2026 · Department of Health and Social Care · Official record
Answered 22 Sep 2026
Question
Asked by Daisy Cooper
To ask the Secretary of State for Health and Social Care, whether she will make representations to NuvationBio to encourage access to the SIGMA Phase 3 trial of Safusideniv for eligible patients at UK hospitals.
Answer
Answered by James Frith, 22 Sep 2026
The Department is supporting engagement with commercial sponsors of clinical trials through the National Institute for Health and Care Research (NIHR) Life Sciences Industry Hub. The NIHR Industry Hub provides a single, nationally coordinated pathway for ...